We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$128M
AUM Growth
-$605K
(-0.47%)
Cap. Flow
-$4.31M
Cap. Flow
% of AUM
-3.36%
Top 10 Holdings %
Top 10 Hldgs %
30.46%
Holding
151
New
9
Increased
24
Reduced
61
Closed
14
Avg Time Held Equity + Options
10.6
quarters
Top 10 Avg Time Held Equity + Options
7.7
quarters
Top 20 Avg Time Held Equity + Options
8.9
quarters
Avg Time Held Equity only
10.6
quarters
Top 10 Avg Time Held Equity only
7.7
quarters
Top 20 Avg Time Held Equity only
8.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$960K |
| 2 |
Medtronic
MDT
|
+$955K |
| 3 |
Walt Disney
DIS
|
+$627K |
| 4 |
CORR
CorEnergy Infrastructure Trust, Inc.
CORR
|
+$603K |
| 5 |
Johnson & Johnson
JNJ
|
+$573K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.23M |
| 2 |
Merck
MRK
|
+$1.04M |
| 3 |
General Motors
GM
|
+$1.02M |
| 4 |
iShares Mortgage Real Estate ETF
REM
|
+$990K |
| 5 |
AbbVie
ABBV
|
+$982K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.53% |
| 2 | Healthcare | 15.93% |
| 3 | Real Estate | 15.05% |
| 4 | Financials | 12.27% |
| 5 | Technology | 12.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
BK Technologies
BKTI
$272M
| $5.39M | 4.21% |
303,695
-1,840
| -0.6% | -$34.2K |
2013 Q2
18 quarters
|
|
2
Bristol-Myers Squibb
BMY
$118B
| $5.27M | 4.11% |
86,000
-12,034
| -12% | -$753K |
2013 Q3
17 quarters
|
|
|
3
General Motors
GM
$72.3B
| $4.69M | 3.66% |
114,493
-23,575
| -17% | -$1.02M |
2014 Q3
13 quarters
|
|
4
Microsoft
MSFT
$4.02T
| $3.69M | 2.88% |
43,105
-260
| -0.6% | -$21.3K |
2013 Q2
18 quarters
|
|
5
Pfizer
PFE
$162B
| $3.63M | 2.83% |
105,479
-11,172
| -10% | -$381K |
2013 Q2
18 quarters
|
|
6
Arbor Realty Trust
ABR
$528M
| $3.42M | 2.66% |
395,419
| – | – |
2013 Q2
18 quarters
|
|
7
Berkshire Hathaway Class A
BRK.A
$1.11T
| $3.27M | 2.55% |
11
| – | – |
2014 Q1
15 quarters
|
|
8
KKR & Co
KKR
$82.1B
| $3.26M | 2.55% |
154,973
-4,985
| -3% | -$100K |
2014 Q2
14 quarters
|
|
9
Hercules Capital
HTGC
$3.1B
| $3.26M | 2.54% |
248,462
+1,300
| +0.5% | +$17K |
2013 Q2
18 quarters
|
|
10
Medical Properties Trust
MPT
$1.88B
| $3.16M | 2.47% |
229,350
-2,500
| -1% | -$33.8K |
2015 Q2
10 quarters
|
|
11
Sprott Physical Gold
PHYS
$14.9B
| $3M | 2.34% |
283,671
-1,000
| -0.4% | -$10.4K |
2013 Q2
18 quarters
|
|
12
Apple
AAPL
$4.98T
| $2.78M | 2.17% |
65,788
+9,944
| +18% | +$416K |
2013 Q2
18 quarters
|
|
13
Mondelez International
MDLZ
$78.9B
| $2.55M | 1.99% |
59,523
| – | – |
2013 Q2
18 quarters
|
|
|
RLH
14
DELISTED
Red Lions Hotel Corporation
RLH
| $2.45M | 1.91% |
249,141
+6,200
| +3% | +$55.3K |
2013 Q2
18 quarters
|
|
15
DELISTED
Walgreens Boots Alliance
WBA
| $2.27M | 1.77% |
31,250
-300
| -1% | -$21.1K |
2016 Q2
6 quarters
|
|
16
Citigroup
C
$221B
| $2.26M | 1.76% |
30,320
| – | – |
2014 Q3
13 quarters
|
|
17
WisdomTree Japan Hedged Equity Fund
DXJ
$2.38B
| $2.18M | 1.7% |
110,190
+3,000
| +3% | +$57.7K |
2017 Q2
2 quarters
|
|
18
DELISTED
DigitalBridge
DBRG
| $2.13M | 1.66% |
46,734
-458
| -1% | -$22.5K |
2017 Q1
3 quarters
|
|
19
Chimera Investment
CIM
$733M
| $1.98M | 1.55% |
35,727
| – | – |
2014 Q1
15 quarters
|
|
20
AT&T
T
$154B
| $1.83M | 1.43% |
62,390
+19,217
| +45% | +$525K |
2015 Q2
10 quarters
|
|
21
MFA Financial
MFA
$675M
| $1.83M | 1.42% |
57,631
-1,000
| -2% | -$33K |
2013 Q2
18 quarters
|
|
|
SIR
22
DELISTED
SELECT INCOME REIT
SIR
| $1.77M | 1.38% |
160,729
-6,370
| -4% | -$69.6K |
2014 Q2
14 quarters
|
|
|
AERI
23
DELISTED
Aerie Pharmaceuticals
AERI
| $1.77M | 1.38% |
29,600
+200
| +0.7% | +$12.1K |
2014 Q3
13 quarters
|
|
24
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.69M | 1.32% |
94,900
| – | – |
2013 Q2
18 quarters
|
|
25
Devon Energy
DVN
$53.9B
| $1.68M | 1.31% |
40,553
-1,200
| -3% | -$45.4K |
2013 Q2
18 quarters
|
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Benchmark Capital Advisors held 151 positions worth $128M, down 0.47% from $129M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Benchmark Capital Advisors withdrew a net $4.31M in Q4 2017, closing 14 positions and reducing 61 holdings. Its most notable exit was Procter & Gamble, an estimated $1.23M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Real Estate.
Against the trend, Benchmark Capital Advisors opened a new position in Intel worth $1.02M.
- Benchmark Capital Advisors's largest Q4 2017 buy was Intel: 22,000 shares worth $1.02M.
- Benchmark Capital Advisors added most to Walt Disney in Q4 2017, an estimated $627K increase.
- Benchmark Capital Advisors's biggest Q4 2017 reduction was General Motors, cutting an estimated $1.02M.
- Benchmark Capital Advisors fully exited Procter & Gamble in Q4 2017, selling an estimated $1.23M.
- Benchmark Capital Advisors's ten largest holdings make up 30% of its $128M portfolio in Q4 2017.
- Benchmark Capital Advisors opened 9 new positions and closed 14 in Q4 2017.
- Benchmark Capital Advisors's portfolio value fell 0.47% quarter-over-quarter to $128M.
Based on Benchmark Capital Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.